Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions, announces that it has acquired Spesana and its best-in-class suite of patient navigation, clinical collaboration, and oncology clinical decision support utilities. Spesana, founded in 2019, has developed a healthcare platform that increases the velocity, efficiency, and utility of innovative precision medicine programs. The Company’s patient navigation, prior authorization, clinical trial collaboration, and diagnostic workflow solutions are in use across over 140 clinical sites, and its blue-chip customer base includes leading payers, multi-site provider and oncology organizations, and diagnostic laboratories.
Read the full article: Aranscia Acquires Spesana //
Source: https://www.prnewswire.com/news-releases/aranscia-acquires-spesana-302452431.html